Recombinant IL23A (Tildrakizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL23A (Tildrakizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7488009
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL23A (Tildrakizumab Biosimilar) antibody (ABIN7488009)
Target
IL23A (Tildrakizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL23A (Tildrakizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Tildrakizumab Biosimilar - Anti-IL23A mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL23A (Tildrakizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
MK-3222, SCH900222
Tildrakizumab is a humanized IgG1 kappa antibody that targets interleukin 23 p19 with high affinity. It is investigated for the treatment of chronic plaque psoriasis. -
CAS-No
- 1326244-10-3
Target
-
You are here:
